copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
AstraZeneca | Cafepharma AstraZeneca on Thursday appointed company insider Rick Suarez as the head of its U S biopharmaceuticals unit to lead the drugmaker's $50 billion investment plan in the company's largest market
AstraZeneca | Cafepharma Message Boards | Pharma Sales, Device Sales . . . Anonymous board for AstraZeneca We’ve seen a growing number of threads touching on AI tools—everything from ChatGPT to internal company initiatives—but mostly in bits and pieces We’re running a short, anonymous survey to better understand how pharma reps (and others in the industry) are actually using AI today, what concerns they have, and what kind of guidance would be most useful
July 24 2025 - AstraZeneca drug acquired in Alexion deal succeeds in . . . AstraZeneca drug acquired in Alexion deal succeeds in autoimmune disease trialAstraZeneca boardPharma giant Roche sees income soar in first halfRoche boardNovartis to pay Matchpoint up to $1 billion to develop anti-inflammatory therapiesNovartis boardHow Bristol Myers Squibb uses AI to validate drugs before they’re even in the lab
Cafepharma News Latest news and updates on pharmaceutical and medical sales, including breakthrough treatments and industry trends
Pfizer | Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales Anonymous board for Pfizer We’ve seen a growing number of threads touching on AI tools—everything from ChatGPT to internal company initiatives—but mostly in bits and pieces We’re running a short, anonymous survey to better understand how pharma reps (and others in the industry) are actually using AI today, what concerns they have, and what kind of guidance would be most useful The
Cafepharma - Home | pharma sales, device sales, lab sales | Cafepharma JPM26: AstraZeneca's $80B revenue target 'very much within reach,' CFO says Fierce Pharma Wednesday, January 14, 2026 - 11:55 am AstraZeneca, JPMHC 2026 AstraZeneca board JPM26: As lenacapavir momentum builds, Gilead eyes new deals from a 'position of strength' Fierce Biotech
AstraZeneca Deepens Cancer Cell Therapy Portfolio with Neogene Buyout . . . AstraZeneca and Neogene Therapeutics have entered into a definitive acquisition agreement in which AstraZeneca will buy all outstanding equity in the smaller company The deal aims to advance T-cell receptor therapies against solid tumors, California-based Neogene announced Tuesday
GlaxoSmithKline | Cafepharma Message Boards | Pharma Sales, Device . . . Anonymous board for GlaxoSmithKline We’ve seen a growing number of threads touching on AI tools—everything from ChatGPT to internal company initiatives—but mostly in bits and pieces We’re running a short, anonymous survey to better understand how pharma reps (and others in the industry) are actually using AI today, what concerns they have, and what kind of guidance would be most